Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
CD19-positive Relapsed or Refractory B-cell Malignancies
Hefei, Anhui
CD19-positive Relapsed or Refractory B-cell Malignancies Clinical Trials in Hefei, Anhui
1 recruiting
Hefei, Anhui, China
Showing
1–1
of
1
trials
Recruiting
Early Phase 1
UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.
CD19-positive Relapsed or Refractory B-cell Malignancies
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
10 enrolled
1 location
NCT06092047
Feedback